News/ News/ Oncology Epizyme eyes lucrative use for newly-launched Tazverik Richard Staines cancer, Constellation Pharmaceuticals, fda, follicular lymphoma, non-Hodgkin lymphoma, Pfizer, tazemetostat, Tazverik 0 Comment US biotech Epizyme is gearing up for a potentially lucrative second indication for its Tazverik (tazemetostat), after the Share X Epizyme eyes lucrative use for newly-launched Tazverik https://pharmaphorum.com/news/epizyme-eyes-lucrative-use-for-newly-launched-tazverik/